Most previous studies that have explored the role of TG metabolism in cardiovascular disease have focused on TRL or their remnants derived from the partial lipolysis of apolipoprotein B-48 and apolipoprotein B100-containing lipoproteins, with less emphasis on exploring the role of the TG content of LDL. The gene discussed is APOB; the disease is cardiovascular disorder.